LEXARIA BIOSCIENCE CORP. Class of Warrant or Right, Outstanding
LEXARIA BIOSCIENCE CORP. (LEXX) had Class of Warrant or Right, Outstanding of 11.09 million shares as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-07-13
- 2026-05-31: Class of Warrant or Right, Outstanding 11.09M shares.
- 2026-02-28: Class of Warrant or Right, Outstanding 11.09M shares.
- 2025-11-30: Class of Warrant or Right, Outstanding 10.06M shares.
- 2025-08-31: Class of Warrant or Right, Outstanding 7.30M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-05-31 | 11.09M shares 10-Q · filed 2026-07-13 | |
| 2026-02-28 | 11.09M shares 10-Q · filed 2026-04-13 | |
| 2025-11-30 | 10.06M shares 10-Q · filed 2026-01-13 | |
| 2025-08-31 | 7.30M shares 10-Q · filed 2026-07-13 | |
| 2025-05-31 | 7.30M shares 10-Q · filed 2025-07-14 | |
| 2025-02-28 | 7.56M shares 10-Q · filed 2025-04-14 | |
| 2024-11-30 | 2.95M shares 10-Q · filed 2025-01-10 | |
| 2024-08-31 | 5.93M shares 10-K · filed 2025-11-28 | |
| 2024-05-31 | 5.93M shares 10-Q · filed 2024-07-12 | |
| 2024-02-29 | 6.63M shares 10-Q · filed 2024-04-09 | |
| 2023-11-30 | 5.54M shares 10-Q · filed 2024-01-12 | |
| 2023-08-31 | 4.52M shares 10-K · filed 2025-11-28 | |
| 2023-05-31 | 4.52M shares 10-Q · filed 2025-07-14 | |
| 2023-02-28 | 2.41M shares 10-Q · filed 2023-04-14 | |
| 2022-11-30 | 2.41M shares 10-Q/A · filed 2023-01-18 | |
| 2022-08-31 | 2.42M shares 10-Q · filed 2025-07-14 | |
| 2022-05-31 | 2.42M shares 10-Q · filed 2022-07-14 | |
| 2022-02-28 | 2.42M shares 10-Q/A · filed 2023-01-18 | |
| 2021-11-30 | 2.42M shares 10-Q/A · filed 2023-01-18 | |
| 2021-08-31 | 2.45M shares 10-Q · filed 2025-07-14 | |
| 2021-05-31 | 3.06M shares 10-Q · filed 2022-04-11 | |
| 2021-02-28 | 2.77M shares 10-Q · filed 2021-04-14 | |
| 2020-11-30 | 439.10K shares 10-Q · filed 2021-01-14 | |
| 2020-08-31 | 471.61K shares 10-Q/A · filed 2023-01-18 | 14.15M shares 10-K · filed 2020-10-15 |
| 2020-05-31 | 14.15M shares 10-Q · filed 2020-06-29 | |
| 2020-02-29 | 4.13M shares 10-Q · filed 2020-04-03 | |
| 2019-11-30 | 4.88M shares 10-Q · filed 2020-01-09 | |
| 2019-08-31 | 94.18K shares 10-Q · filed 2022-04-11 | 2.83M shares 10-K · filed 2019-11-14 |
| 2019-05-31 | 3.03M shares 10-Q · filed 2019-07-08 | |
| 2019-02-28 | 3.32M shares 10-Q · filed 2019-04-15 | |
| 2018-11-30 | 3.95M shares 10-Q · filed 2019-01-11 | |
| 2018-08-31 | 3.29M shares 10-Q/A · filed 2023-01-18 | |
| 2018-05-31 | 5.93M shares 10-Q · filed 2018-07-13 | |
| 2018-02-28 | 6.98M shares 10-Q · filed 2018-04-12 | |
| 2017-11-30 | 7.46M shares 10-Q · filed 2018-01-12 | |
| 2017-08-31 | 8.84M shares 10-K · filed 2019-11-14 | |
| 2016-08-31 | 12.14M shares 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |